GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ANG Lifesciences India Ltd (BOM:540694) » Definitions » Deferred Tax

ANG Lifesciences India (BOM:540694) Deferred Tax : ₹0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is ANG Lifesciences India Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

ANG Lifesciences India's change in deferred tax for the three months ended in Dec. 2024 was ₹0 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Dec. 2024 was ₹0 Mil.

ANG Lifesciences India Deferred Tax Historical Data

The historical data trend for ANG Lifesciences India's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ANG Lifesciences India Deferred Tax Chart

ANG Lifesciences India Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.11 31.11 - - -

ANG Lifesciences India Quarterly Data
Sep19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

ANG Lifesciences India Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ANG Lifesciences India Deferred Tax Related Terms

Thank you for viewing the detailed overview of ANG Lifesciences India's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

ANG Lifesciences India Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ANG Lifesciences India Ltd (BOM:540694) » Definitions » Deferred Tax
Comparable Companies
NSE:VILINBIO BOM:539938 NSE:MEDIORG BOM:524314 BOM:542934 BOM:543963 BOM:538965 BOM:532167 BOM:511523 BOM:524322 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
Ranjit Avenue, B-Block, Darbara Complex, SCO 113, First Floor, District Shopping Complex, Amritsar, PB, IND, 143001
Website
https://www.anglifesciences.com
ANG Lifesciences India Ltd is an India-based engaged in the manufacturing of finished pharmaceutical formulations in the form of dry powder for injections. The Group has two reportable segments: Pharmaceuticals which include Manufacturing of pharmaceutical products, and Packaging and printing which include Prinitng and packaging. Key revenue is generated from Pharmaceuticals.

ANG Lifesciences India Headlines

No Headlines